Foamix Pharmaceuticals Ltd. Stock-Based Compensation
Foamix Pharmaceuticals Ltd. reported Stock-Based Compensation of $4.89 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2020-03-12
- Foamix Pharmaceuticals Ltd. share-based payment arrangement, noncash expense for the quarter ending 2019-12-31 was $1.29M, a 9.61% increase year-over-year.
- Foamix Pharmaceuticals Ltd. share-based payment arrangement, noncash expense for the quarter ending 2019-09-30 was $1.27M, a 6.64% increase year-over-year.
- Foamix Pharmaceuticals Ltd. share-based payment arrangement, noncash expense for the quarter ending 2019-06-30 was $1.39M, a 15.67% increase year-over-year.
- Foamix Pharmaceuticals Ltd. share-based payment arrangement, noncash expense for the quarter ending 2019-03-31 was $950.00K, a 45.84% decline year-over-year.
- Foamix Pharmaceuticals Ltd. share-based payment arrangement, noncash expense for fiscal 2019 was $4.89M, a 7.99% decline from fiscal 2018.
- Foamix Pharmaceuticals Ltd. share-based payment arrangement, noncash expense for fiscal 2018 was $5.32M, a 27.70% increase from fiscal 2017.
- Foamix Pharmaceuticals Ltd. share-based payment arrangement, noncash expense for fiscal 2017 was $4.17M, a 43.06% increase from fiscal 2016.
- Foamix Pharmaceuticals Ltd. share-based payment arrangement, noncash expense for fiscal 2016 was $2.91M, a 63.87% increase from fiscal 2015.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2019-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $2.56M derived: sum of 2 quarters · filed 2020-03-12 | $3.95M derived: sum of 3 quarters · filed 2020-03-12 | $4.89M 10-K · filed 2020-03-12 |
| 2019-09-30 | $1.27M 10-Q · filed 2019-11-12 | $2.66M derived: sum of 2 quarters · filed 2019-11-12 | $3.61M 10-Q · filed 2019-11-12 | $4.78M derived: sum of 4 quarters · filed 2020-03-12 |
| 2019-06-30 | $1.39M 10-Q · filed 2019-08-07 | $2.34M 10-Q · filed 2019-08-07 | $3.51M derived: sum of 3 quarters · filed 2020-03-12 | $4.70M derived: sum of 4 quarters · filed 2020-03-12 |
| 2019-03-31 | $950.00K 10-Q · filed 2019-05-07 | $2.13M derived: sum of 2 quarters · filed 2020-03-12 | $3.32M derived: sum of 3 quarters · filed 2020-03-12 | $4.52M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $2.37M derived: sum of 2 quarters · filed 2020-03-12 | $3.57M derived: sum of 3 quarters · filed 2020-03-12 | $5.32M 10-K · filed 2020-03-12 |
| 2018-09-30 | $1.19M 10-Q · filed 2019-11-12 | $2.39M derived: sum of 2 quarters · filed 2019-11-12 | $4.14M 10-Q · filed 2019-11-12 | $5.63M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | $1.20M 10-Q · filed 2019-08-07 | $2.95M 10-Q · filed 2019-08-07 | $4.44M derived: sum of 3 quarters · filed 2020-03-12 | $5.63M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | $1.75M 10-Q · filed 2019-05-07 | $3.24M derived: sum of 2 quarters · filed 2020-03-12 | $4.43M derived: sum of 3 quarters · filed 2020-03-12 | $5.15M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $2.68M derived: sum of 2 quarters · filed 2020-03-12 | $3.40M derived: sum of 3 quarters · filed 2020-03-12 | $4.17M 10-K · filed 2020-03-12 |
| 2017-09-30 | $1.20M 10-Q · filed 2018-11-07 | $1.92M derived: sum of 2 quarters · filed 2018-11-07 | $2.68M 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $721.00K 10-Q · filed 2018-08-08 | $1.49M 10-Q · filed 2018-08-08 | ||
| 2017-03-31 | $766.00K 10-Q · filed 2018-05-08 | |||
| 2016-12-31 | $2.91M 10-K · filed 2019-02-28 | |||
| 2016-06-30 | $697.00K 6-K · filed 2017-08-08 | $1.23M 6-K · filed 2017-08-08 | ||
| 2015-12-31 | $1.78M 10-K · filed 2018-03-01 | |||
| 2015-06-30 | $707.00K 6-K · filed 2016-08-10 | $859.00K 6-K · filed 2016-08-10 | ||
| 2014-12-31 | $197.00K 20-F · filed 2017-02-21 | |||
| 2014-06-30 | $144.00K 6-K · filed 2015-10-19 | |||
| 2013-12-31 | $505.00K 20-F · filed 2016-03-02 | |||
| 2012-12-31 | $355.00K 20-F · filed 2015-03-17 |